Who
Joseph H. Capper
Director
Company insider
Files Form 4 as: Director, TELA Bio; Director, Anika Therapeutics; Chief Executive Officer, MiMedx Group; Director, Neuronetics; President & CEO, Biotelemetry; President and CEO, CardioNet; President, Home Diagnostics.
In numbers
- Trades disclosed
- 132
- Buys
- 19
- Sells
- 20
- Bought
- $2.4M
- Sold
- $32.3M
- Companies
- 7
- Companies where not an officer
- 3
- First trade
- 23 Feb 2009
- Last trade
- 17 Sep 2026
- Last filed
- 18 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 17 Sep 2026filed 18 Sep 2026 | TELA TELA BioMedical Devices | SEC FORM 4 Bought | $31K25,000 at $1.22 | filing |
| 17 Sep 2026filed 18 Sep 2026 | TELA TELA BioMedical Devices | SEC FORM 4 Bought | $31K25,000 at $1.22 | filing |
| 16 Sep 2026filed 18 Sep 2026 | TELA TELA BioMedical Devices | SEC FORM 4 Bought | $58K50,000 at $1.17 | filing |
| 16 Sep 2026filed 18 Sep 2026 | TELA TELA BioMedical Devices | SEC FORM 4 Bought | $59K50,000 at $1.17 | filing |
| 15 Sep 2026filed 16 Sep 2026 | TELA TELA BioMedical Devices | SEC FORM 4 Bought | $53K50,000 at $1.06 | filing |
| 15 Sep 2026filed 16 Sep 2026 | TELA TELA BioMedical Devices | SEC FORM 4 Bought | $53K50,000 at $1.06 | filing |
| 14 Sep 2026filed 16 Sep 2026 | TELA TELA BioMedical Devices | SEC FORM 4 Bought | $26K25,000 at $1.02 | filing |
| 14 Sep 2026filed 16 Sep 2026 | TELA TELA BioMedical Devices | SEC FORM 4 Bought | $26K25,000 at $1.02 | filing |
| 15 Jul 2026filed 17 Jul 2026 | TELA TELA BioMedical Devices | SEC FORM 4 Code A | $4,8886,227 at $0.785 | filing |
| 15 Jul 2026filed 17 Jul 2026 | TELA TELA BioMedical Devices | SEC FORM 4 Code A | $4,9196,227 at $0.79 | filing |
| 18 Jun 2026filed 23 Jun 2026 | ANIK Anika TherapeuticsMedical Devices | SEC FORM 4 Code A | —10,402 at $0.00 | filing |
| 18 Jun 2026filed 23 Jun 2026 | ANIK Anika TherapeuticsMedical Devices | SEC FORM 4 Code A | —10,402 at $0.00 | filing |
| 9 Jun 2026filed 11 Jun 2026 | TELA TELA BioMedical Devices | SEC FORM 4 Code A | —11,925 at $0.00 | filing |
| 9 Jun 2026filed 11 Jun 2026 | TELA TELA BioMedical Devices | SEC FORM 4 Code A | —11,675 at $0.00 | filing |
| 9 Jun 2026filed 11 Jun 2026 | TELA TELA Biooption or derivative · Medical Devices | SEC FORM 4 Code A | —17,550 at $0.00 | filing |
| 9 Jun 2026filed 11 Jun 2026 | TELA TELA Biooption or derivative · Medical Devices | SEC FORM 4 Code A | —17,550 at $0.00 | filing |
| 9 Jun 2026filed 11 Jun 2026 | TELA TELA Biooption or derivative · Medical Devices | SEC FORM 4 Code A | —17,335 at $0.00 | filing |
| 9 Jun 2026filed 11 Jun 2026 | TELA TELA Biooption or derivative · Medical Devices | SEC FORM 4 Code A | —17,335 at $0.00 | filing |
| 9 Jun 2026filed 11 Jun 2026 | TELA TELA BioMedical Devices | SEC FORM 4 Code A | —11,925 at $0.00 | filing |
| 9 Jun 2026filed 11 Jun 2026 | TELA TELA BioMedical Devices | SEC FORM 4 Code A | —11,675 at $0.00 | filing |
News
TELA Bio (NASDAQ:TELA) versus Shoulder Innovations (NYSE:SI) Head to Head SurveyTELA · dailypolitical.com · 14 Oct 2026TELA Bio Announces 510(k) Clearance for Liora™ Monofilament Scaffold for Soft Tissue Reinforcement – Ortho Spine NewsTELA · orthospinenews.com · 5 Oct 2026
0 headlines in the last 90 days name Joseph H. Capper; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.